Avacta Group Plc (LON:AVCT)‘s stock had its “corporate” rating reiterated by equities researchers at FinnCap in a report issued on Thursday.

Separately, Numis Securities Ltd reissued a “buy” rating on shares of Avacta Group Plc in a research report on Monday, August 1st.

Avacta Group Plc (LON:AVCT) opened at 101.50 on Thursday. Avacta Group Plc has a 12-month low of GBX 83.02 and a 12-month high of GBX 142.50. The company’s 50-day moving average is GBX 99.83 and its 200 day moving average is GBX 103.16. The stock’s market capitalization is GBX 68.15 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/avacta-group-plc-avct-receives-corporate-rating-from-finncap.html

In related news, insider Albin,Michael Scott acquired 3,393 shares of the firm’s stock in a transaction on Thursday, July 7th. The stock was acquired at an average cost of GBX 92 ($1.20) per share, for a total transaction of £3,121.56 ($4,074.61).

Avacta Group Plc Company Profile

Avacta Group plc is a provider of research reagents, consumables and equipment to the life sciences and animal care markets. The Company provides research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology.

Receive News & Ratings for Avacta Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.